Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant

ClinicalTrials.gov ID: NCT02610296

Public ClinicalTrials.gov record NCT02610296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to evaluate the reduction in incidence and severity of delayed graft function with kidney allografts from donors \>45 years after brain death (DBD).

Study identification

NCT ID
NCT02610296
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Quark Pharmaceuticals
Industry
Enrollment
594 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1, 2016 (Actual)
Primary completion
Jun 28, 2018 (Actual)
Completion
Jan 8, 2019 (Actual)
Last update posted
May 13, 2020

2016 – 2019

United States locations

U.S. sites
36
U.S. states
22
U.S. cities
32
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
Mayo Clinic Phoenix Phoenix Arizona 85054 —
University of California, Los Angeles Los Angeles California 90024 —
University of Southern California Los Angeles California 90033 —
University of California, Davis Sacramento California 95817 —
California Pacific Medical Center San Francisco California 94115 —
University of California, San Francisco San Francisco California 94143 —
Stanford University Stanford California 94305 —
University of Colorado, Denver Aurora Colorado 80045 —
Yale University New Haven Connecticut 06519 —
Georgetown Transplant Institute Washington D.C. District of Columbia 20007 —
University of Florida Health, Shands Hospital Gainesville Florida 32608 —
Tampa General Hospital Tampa Florida 33606 —
Emory University Atlanta Georgia 30322 —
University of Louisville Louisville Kentucky 40202 —
Ochsner Medical Center New Orleans Louisiana 70121 —
University of Maryland Baltimore Maryland 21202 —
University of Michigan Ann Arbor Michigan 48109 —
St. Barnabas Medical Center Livingston New Jersey 07039 —
Erie County Medical Center Buffalo New York 14215 —
Icahn School of Medicine at Mt. Sinai New York New York 10029 —
Columbia University New York New York 10032 —
New York - Presbyterian Hospital / Weill Cornell Medical Center New York New York 10065 —
SUNY Upstate NY University Hospital Syracuse New York 13210 —
Duke University Durham North Carolina 27710 —
Wake Forest University Winston-Salem North Carolina 27103 —
Ohio State University Columbus Ohio 43210 —
Integris Nazih Zuhdi Transplant Institute Oklahoma City Oklahoma 73112 —
Medical University of South Carolina Charleston South Carolina 29425 —
Baylor University Medical Center Dallas Texas 75246 —
Baylor All Saints Fort Worth Texas 76104 —
Houston Methodist Hospital Houston Texas 77030 —
University of Virginia Charlottesville Virginia 22908 —
Virginia Commonwealth University Richmond Virginia 23298 —
University of Washington Seattle Washington 98195 —
University of Wisconsin Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02610296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2020 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02610296 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →